Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Sch 530348
2. Sch-530348
3. Sch530348
4. Vorapaxar
5. Zontivity
1. 705260-08-8
2. Zontivity
3. Sch 530348
4. Vorapaxar Sulfate [usan]
5. Vorapaxar Monosulfate
6. Chebi:83314
7. In66038e6c
8. Vorapaxar (sulfate)
9. Ethyl N-[(1r,3ar,4ar,6r,8ar,9s,9as)-9-[(e)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1h-benzo[f][2]benzofuran-6-yl]carbamate;sulfuric Acid
10. Unii-in66038e6c
11. Zontivity (tn)
12. Carbamic Acid, N-((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate (1:1)
13. Carbamic Acid, N-[(1r,3ar,4ar,6r,8ar,9s,9as)-9-[(1e)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, Ethyl Ester, Sulfate (1:1)
14. Sch 530348 Sulfate
15. Vorapaxar Sulfate [mi]
16. Vorapaxar Sulfate (jan/usan)
17. Vorapaxar Sulfate [jan]
18. Chembl2107386
19. Dtxsid60990731
20. Vorapaxar Sulfate [vandf]
21. Sch 530348 H2so4 Salt
22. Vorapaxar Sulfate [who-dd]
23. Amy32612
24. Ex-a1149
25. Hy-10119a
26. Mfcd16038877
27. Akos030524402
28. Vorapaxar Sulfate [orange Book]
29. As-35235
30. Ethyl ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((e)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate Sulfate
31. Cs-0002462
32. D09766
33. Sch 530348 Sulfate; Vorapaxar Sulfate; Mk5348
34. Q27156749
35. 2-[(e)-2-{(3r,3as,4s,4ar,7r,8ar,9ar)-7-[(ethoxycarbonyl)amino]-3-methyl-1-oxododecahydronaphtho[2,3-c]furan-4-yl}ethenyl]-5-(3-fluorophenyl)pyridinium Hydrogen Sulfate
36. Carbamic Acid, ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate
37. Carbamic Acid, ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate (1:1)
38. Ethyl ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)pyridin-2-yl)ethenyl)-1-methyl-3-oxododecahydronaphtho(2,3-c)furan-6-yl)carbamate Sulfate
39. Ethyl [(1r,3ar,4ar,6r,8ar,9s,9as)-9-{(e)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamate Sulfate
Molecular Weight | 590.7 g/mol |
---|---|
Molecular Formula | C29H35FN2O8S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 6 |
Exact Mass | 590.20981541 g/mol |
Monoisotopic Mass | 590.20981541 g/mol |
Topological Polar Surface Area | 161 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 902 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Zontivityis indicated for the reduction of atherothrombotic events in adult patients with
- a history of myocardial infarction (MI), ,co-administered with acetylsalicylic acid (ASA) and, where appropriate, clopidogrel; or
- symptomatic peripheral arterial disease
(PAD), co-administered with acetylsalicylic acid (ASA) or, where appropriate, clopidogrel.
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
B01
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Vorapaxar Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vorapaxar Sulfate, including repackagers and relabelers. The FDA regulates Vorapaxar Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vorapaxar Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vorapaxar Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vorapaxar Sulfate supplier is an individual or a company that provides Vorapaxar Sulfate active pharmaceutical ingredient (API) or Vorapaxar Sulfate finished formulations upon request. The Vorapaxar Sulfate suppliers may include Vorapaxar Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Vorapaxar Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vorapaxar Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Vorapaxar Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Vorapaxar Sulfate DMFs exist exist since differing nations have different regulations, such as Vorapaxar Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vorapaxar Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Vorapaxar Sulfate USDMF includes data on Vorapaxar Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vorapaxar Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vorapaxar Sulfate suppliers with USDMF on PharmaCompass.
Vorapaxar Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vorapaxar Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vorapaxar Sulfate GMP manufacturer or Vorapaxar Sulfate GMP API supplier for your needs.
A Vorapaxar Sulfate CoA (Certificate of Analysis) is a formal document that attests to Vorapaxar Sulfate's compliance with Vorapaxar Sulfate specifications and serves as a tool for batch-level quality control.
Vorapaxar Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Vorapaxar Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vorapaxar Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vorapaxar Sulfate EP), Vorapaxar Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vorapaxar Sulfate USP).
LOOKING FOR A SUPPLIER?